Patients with multiple myeloma treated with thalidomide: evaluation of clinical parameters, cytokines, angiogenic markers, mast cells and marrow CD57+ cytotoxic T cells as predictors of outcome
Haematologica Mileshkin et al.
92: 1075
Mileshkin et al. Supplementary Appendix
Additional appendix provided by the author
Files in this Data Supplement: